Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-072872·CUMBERLAND PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Cumberland Pharmaceuticals, Inc.
Common Stock, no par value · CUSIP: 230770109
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ikarian Capital, LLC
Shares: 730,932 · Class: 4.9%
- Neil Shahrestani
Shares: 730,932 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-072872
- Form type
- SCHEDULE 13G
- Filer
- CUMBERLAND PHARMACEUTICALS INC
- CIK
- CIK 1087294
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership